ClinicalMetric tracks all active clinical trials for tdcs sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Top Sponsors
1 trial
1 trial
1 trial
NCT06212609
Recruiting
Optimized and Personalized Trans-cranial Brain Stimulation in Partial Refractory Epilepsies
Enrollment
20 pts
Location
France
Sponsor
Centre Hospitalier Universitai...
NCT07438808
Recruiting
Influence of Physical Exercise on Neuroplasticity and Sensorimotor Networks in Older Adults
Enrollment
66 pts
Location
France
Sponsor
Universite du Littoral Cote d'...
NCT07203339
Recruiting
Home-based Transcranial Direct Current Stimulation (tDCS) Compared to Duloxetine: Non-inferiority Clinical Trial (FIBROSTIM)
Enrollment
610 pts
Location
Brazil
Sponsor
Hospital de Clinicas de Porto ...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology